Vericel Corp. (VCEL)
35.68
+1.91
(+5.66%)
USD |
NASDAQ |
Apr 17, 16:00
35.68
0.00 (0.00%)
After-Hours: 20:00
Vericel SG&A Expense (Quarterly) : 43.46M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Arbutus Biopharma Corp. | 3.689M |
| Marker Therapeutics, Inc. | 0.8466M |
| Moderna, Inc. | 308.00M |
| Krystal Biotech, Inc. | 41.45M |
| Tenaya Therapeutics, Inc. | 5.977M |